Creative Medical Technology Holdings, Inc.(CELZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CELZ Creative Medical Technology Holdings, Inc.

Closed Good Friday 04-17 16:00:00 EDT

1.97

-0.01

-0.51%

盘后1.97

+0.000.00%

19:08 EDT

High2.03	Low1.91	Vol78.52K
Open1.98	D1 Closing1.98	Amplitude6.06%
Mkt Cap3.44M	Tradable Cap2.92M	Total Shares1.75M
T/O153.89K	T/O Rate5.30%	Tradable Shares1.48M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"CELZ","market":"US","secType":"STK","nameCN":"Creative Medical Technology Holdings, Inc.","latestPrice":1.97,"timestamp":1744920000000,"preClose":1.98,"halted":0,"volume":78518,"hourTrading":{"tag":"盘后","latestPrice":1.97,"preClose":1.97,"latestTime":"19:08 EDT","volume":56,"amount":108.8366,"timestamp":1744931328889},"delay":0,"floatShares":1481656,"shares":1748428,"eps":-3.710758,"marketStatus":"Closed Good Friday","change":-0.01,"latestTime":"04-17 16:00:00 EDT","open":1.98,"high":2.03,"low":1.9101,"amount":153890.6709934,"amplitude":0.060556,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.710758,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.98,"postHourTrading":{"tag":"盘后","latestPrice":1.97,"preClose":1.97,"latestTime":"19:08 EDT","volume":56,"amount":108.8366,"timestamp":1744931328889},"volumeRatio":0.3715382700087278},"requestUrl":"/m/hq/s/CELZ","defaultTab":"news","newsList":[{"id":"2524441661","title":"Creative Medical Technology files to sell 1.8M shares of common for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2524441661","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524441661?lang=en_us&edition=full_marsco","pubTime":"2025-04-03 04:50","pubTimestamp":1743627013,"startTime":"0","endTime":"0","summary":"16:49 EDT Creative Medical Technology (CELZ) files to sell 1.8M shares of common for holders Published first on TheFly – the ultimate source for re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/creative-medical-technology-files-to-sell-1-8m-shares-of-common-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/creative-medical-technology-files-to-sell-1-8m-shares-of-common-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CELZ","BK4139"],"gpt_icon":0},{"id":"2521628634","title":"Creative Medical Technology price target lowered to $26 from $30 at Roth MKM","url":"https://stock-news.laohu8.com/highlight/detail?id=2521628634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521628634?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 20:30","pubTimestamp":1742560245,"startTime":"0","endTime":"0","summary":"Roth MKM lowered the firm’s price target on Creative Medical Technology (CELZ) to $26 from $30 but keeps a Buy rating on the shares after its 10-K ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/creative-medical-technology-price-target-lowered-to-26-from-30-at-roth-mkm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/creative-medical-technology-price-target-lowered-to-26-from-30-at-roth-mkm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CELZ"],"gpt_icon":0},{"id":"2521494357","title":"Creative Medical Technology Holdings Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2521494357","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521494357?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 05:01","pubTimestamp":1742504511,"startTime":"0","endTime":"0","summary":"Creative Medical Technology Holdings Inc reports results for the quarter ended December 31 - Earnings SummaryCreative Medical Technology Holdings Inc CELZ.OQ reported a quarterly adjusted loss of $1.1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nL8N3Q32DR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELZ"],"gpt_icon":0},{"id":"2520455938","title":"Creative Medical Receives FDA Approval to Expand Dosing in Back Pain Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2520455938","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520455938?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 20:16","pubTimestamp":1742472998,"startTime":"0","endTime":"0","summary":"Creative Medical Technology  said Thursday the US Food and Drug Administration has allowed an increased dosing plan in its ongoing phase 1/2 trial of its cell therapy targeting chronic lower back pain caused by degenerative disc disease.The decision follows interim blinded results showing significant pain reduction and mobility improvements with the use of CELZ-201-DDT among trial participants, the company said.The FDA authorization allows the trial to move forward with dose escalation, which has already been approved by the study's safety and ethics boards.Creative Medical said no serious side effects or dose-limiting toxicities have been reported halfway through the study.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CELZ"],"gpt_icon":0},{"id":"2520531734","title":"Creative Medical secures FDA clearance for dose escalation in Phase 1/2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2520531734","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520531734?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 19:55","pubTimestamp":1742471749,"startTime":"0","endTime":"0","summary":"Creative Medical Technology (CELZ) Holdings announced that the U.S. Food and Drug Administration has cleared an expanded dose escalation for its on...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/creative-medical-secures-fda-clearance-for-dose-escalation-in-phase-1-2-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/creative-medical-secures-fda-clearance-for-dose-escalation-in-phase-1-2-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CELZ","BK4139"],"gpt_icon":0},{"id":"2520145388","title":"Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of Celz-201-Ddt for Chronic Lower Back Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2520145388","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520145388?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 19:50","pubTimestamp":1742471400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA4XK5S3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CELZ","BK4139"],"gpt_icon":0},{"id":"2520931725","title":"Creative Medical Technology Holdings Inc  expected to post a loss of 64 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2520931725","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520931725?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 04:10","pubTimestamp":1742328611,"startTime":"0","endTime":"0","summary":"Creative Medical Technology Holdings Inc  expected to post a loss of64cents a share - Earnings Preview Creative Medical Technology Holdings Inc CELZ.OQ CELZ.O is expected to show no change in quarterl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nL8N3Q121U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELZ"],"gpt_icon":0},{"id":"2519309560","title":"Creative Medical Technology Holdings, Inc.'s (NASDAQ:CELZ) Shift From Loss To Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2519309560","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519309560?lang=en_us&edition=full_marsco","pubTime":"2025-03-16 22:14","pubTimestamp":1742134449,"startTime":"0","endTime":"0","summary":"With the business potentially at an important milestone, we thought we'd take a closer look at Creative Medical Technology Holdings, Inc.'s  future prospects. Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The US$5.7m market-cap company announced a latest loss of US$5.5m on 31 December 2024 for its most recent financial year result. Many investors are wondering about the rate at which Creative Medical Technology Holdings will turn a profit, with the big question being “when will the company breakeven?”In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable.View our latest analysis for Creative Medical Technology Holdings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/creative-medical-technology-holdings-inc-141409376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USAW.SI","BK4139","USJW.SI","BK4588","LU2095319765.USD","BK4112","TSYW.SI","CELZ","MNQmain","LU2210149790.SGD","BK4585","IE00BGHQF748.EUR",".IXIC","LU2210150020.SGD","IE00B64PRP62.GBP","NQmain","IE00B3QW5Z07.USD","NVIW.SI","PSQ","NDAQ","QID","QLD","IE00BKPKM429.USD","TQQQ","SQQQ"],"gpt_icon":1},{"id":"2517157755","title":"Creative Medical announces agreements for exercise of warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2517157755","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517157755?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 21:28","pubTimestamp":1741267684,"startTime":"0","endTime":"0","summary":"Creative Medical Technology (CELZ) has entered into agreements with certain holders of its existing warrants for the immediate exercise of certain ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/creative-medical-announces-agreements-for-exercise-of-warrants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/creative-medical-announces-agreements-for-exercise-of-warrants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CELZ","BK4139"],"gpt_icon":0},{"id":"2517389152","title":"Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2517389152","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517389152?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 21:10","pubTimestamp":1741266652,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP1GY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CELZ"],"gpt_icon":0},{"id":"2517152712","title":"Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2517152712","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517152712?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 21:10","pubTimestamp":1741266600,"startTime":"0","endTime":"0","summary":"PHOENIX, March 06, 2025  -- Creative Medical Technology Holdings, Inc.,  , a leading biotechnology innovator in regenerative medicine, today announced it has entered into agreements with certain holders of its existing warrants for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 837,104 shares of common stock of the Company originally issued in October 2024 at their current exercise price of $4.42 per share. The shares of common stock issuable upon exercise of the existing warrants are registered pursuant to an effective registration statement on Form S-1 . The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $3.7 million, before deducting financial advisory fees.Roth Capital Partners is acting as the Company’s financial advisor for this transaction.In consideration for the immediate exercise of the existing warrants for cash, the Company will issue new unregistered warrants to purchase share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/creative-medical-technology-holdings-announces-131000080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CELZ","BK4139"],"gpt_icon":1},{"id":"2511069340","title":"BUZZ-Creative Medical Technology rises on positive data for stem cell therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2511069340","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511069340?lang=en_us&edition=full_marsco","pubTime":"2025-02-14 22:07","pubTimestamp":1739542072,"startTime":"0","endTime":"0","summary":"BUZZ-Creative Medical Technology rises on positive data for stem cell therapy** Shares of biotech firm Creative Medical Technology Holdings CELZ.O rise 16.1% to $5.33 premarket** Co says its mid-term ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nL4N3P513J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELZ","BK4139"],"gpt_icon":0},{"id":"2511661043","title":"Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing Stemspine® Procedure Using Allostem™","url":"https://stock-news.laohu8.com/highlight/detail?id=2511661043","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511661043?lang=en_us&edition=full_marsco","pubTime":"2025-02-14 20:00","pubTimestamp":1739534452,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nTUA5ZPJ9Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CELZ"],"gpt_icon":0},{"id":"2511664082","title":"Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™","url":"https://stock-news.laohu8.com/highlight/detail?id=2511664082","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511664082?lang=en_us&edition=full_marsco","pubTime":"2025-02-14 20:00","pubTimestamp":1739534400,"startTime":"0","endTime":"0","summary":"Study Demonstrates Robust Efficacy and Strong Safety Profile. PHOENIX, Feb. 14, 2025  -- Creative Medical Technology Holdings, Inc.  , a pioneering biotechnology firm specializing in regenerative medicine solutions for immunotherapy, endocrinology, urology, gynecology, and orthopedics, today announced compelling mid-term follow-up data from its StemSpine pilot study utilizing its AlloStem cells for the treatment of chronic lower back pain.The pilot study demonstrated a substantial reduction in opioid dependency and significant improvements in pain levels and functional mobility. Notably, over 90% of patients reported no opioid use for pain management three years post-procedure, with an 80% persistent reduction in pain scores and a greater than 60% improvement in Oswestry Disability Index scores. Only one patient required reintervention at the three-year follow-up mark, and no serious adverse events were reported, reinforcing the favorable safety profile of the StemSpine procedure.Forwa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/creative-medical-technology-holdings-announces-120000449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CELZ"],"gpt_icon":0},{"id":"2510938751","title":"Creative Medical Technology reports one-year results for AlloStem program","url":"https://stock-news.laohu8.com/highlight/detail?id=2510938751","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510938751?lang=en_us&edition=full_marsco","pubTime":"2025-02-11 22:30","pubTimestamp":1739284253,"startTime":"0","endTime":"0","summary":"Creative Medical Technology (CELZ) announced one-year follow-up data from the AlloStem Type 2 Diabetes pilot study for late-stage patients. CELZ-20...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/creative-medical-technology-reports-one-year-results-for-allostem-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/creative-medical-technology-reports-one-year-results-for-allostem-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CELZ","BK4139"],"gpt_icon":0},{"id":"2510382424","title":"Creative Medical Technology Holdings Inc - Announces Promising One-Year Data From Allostem Type 2 Diabetes Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2510382424","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510382424?lang=en_us&edition=full_marsco","pubTime":"2025-02-11 22:27","pubTimestamp":1739284039,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nFWN3P211K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CELZ","BK4139"],"gpt_icon":0},{"id":"2510382420","title":"Creative Medical Technology Holdings Inc - Celz-201 Achieves 80% Efficacy in Reducing Insulin Dependency","url":"https://stock-news.laohu8.com/highlight/detail?id=2510382420","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510382420?lang=en_us&edition=full_marsco","pubTime":"2025-02-11 22:27","pubTimestamp":1739284039,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nFWN3P211K:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CELZ","BK4139"],"gpt_icon":0},{"id":"2510387248","title":"Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2510387248","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510387248?lang=en_us&edition=full_marsco","pubTime":"2025-02-11 22:25","pubTimestamp":1739283900,"startTime":"0","endTime":"0","summary":"Significant Efficacy and No Serious Adverse Effects Observed with CELZ-201. PHOENIX, Feb. 11, 2025  -- Creative Medical Technology Holdings, Inc. , a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced promising one-year follow-up data from the AlloStem   Type 2 Diabetes pilot study for late-stage patients. CELZ-201 is an off the shelf, ready-to-use universal and proprietary allogenic  cell line developed by the Company.Results demonstrate that CELZ-201 achieved an 80% overall efficacy rate in reducing insulin dependency and stabilizing hemoglobin A1c levels, with no serious adverse effects reported.The study, which included 20 patients—10 receiving CELZ-201 and 10 undergoing optimized medical therapy—validated the safety and efficacy of CELZ-201 through the same infusion procedure used in the Company’s U.S. FDA-cleared Type 1 Diabetes clinical trial, which is currently underway. The absence of safety concerns further supports the potential o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/creative-medical-technology-reports-positive-142500212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CELZ"],"gpt_icon":0},{"id":"2509051285","title":"Creative Medical Technology expands collaboration with Greenstone Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2509051285","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509051285?lang=en_us&edition=full_marsco","pubTime":"2025-02-05 21:30","pubTimestamp":1738762223,"startTime":"0","endTime":"0","summary":"Creative Medical Technology (CELZ) announced an expanded agreement with Greenstone Biosciences to leverage Artificial Intelligence in further devel...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/creative-medical-technology-expands-collaboration-with-greenstone-biosciences?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/creative-medical-technology-expands-collaboration-with-greenstone-biosciences?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CELZ","BK4139"],"gpt_icon":0},{"id":"2509285288","title":"Creative Medical Technology Holdings Expands Collaboration With Greenstone Biosciences to Accelerate Ipscelz Pipeline Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2509285288","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509285288?lang=en_us&edition=full_marsco","pubTime":"2025-02-05 21:25","pubTimestamp":1738761900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nTUA6NJLJX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CELZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.creativemedicaltechnology.com","stockEarnings":[{"period":"1week","weight":0.0944},{"period":"1month","weight":-0.3411},{"period":"3month","weight":-0.1322},{"period":"6month","weight":-0.5533},{"period":"1year","weight":-0.6056},{"period":"ytd","weight":-0.1472}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.051206},{"month":2,"riseRate":0.333333,"avgChangeRate":0.040048},{"month":3,"riseRate":0.333333,"avgChangeRate":0.208196},{"month":4,"riseRate":0.5,"avgChangeRate":4.609751},{"month":5,"riseRate":0,"avgChangeRate":-0.28061},{"month":6,"riseRate":0.444444,"avgChangeRate":0.275911},{"month":7,"riseRate":0.25,"avgChangeRate":-0.08343},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.121358},{"month":9,"riseRate":0.125,"avgChangeRate":-0.235861},{"month":10,"riseRate":0.125,"avgChangeRate":-0.133958},{"month":11,"riseRate":0.125,"avgChangeRate":-0.216578},{"month":12,"riseRate":0.25,"avgChangeRate":1.815282}],"exchange":"NASDAQ","name":"Creative Medical Technology Holdings, Inc.","nameEN":"Creative Medical Technology Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Creative Medical Technology Holdings, Inc.(CELZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Creative Medical Technology Holdings, Inc.(CELZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Creative Medical Technology Holdings, Inc.,CELZ,Creative Medical Technology Holdings, Inc.股票,Creative Medical Technology Holdings, Inc.股票老虎,Creative Medical Technology Holdings, Inc.股票老虎国际,Creative Medical Technology Holdings, Inc.行情,Creative Medical Technology Holdings, Inc.股票行情,Creative Medical Technology Holdings, Inc.股价,Creative Medical Technology Holdings, Inc.股市,Creative Medical Technology Holdings, Inc.股票价格,Creative Medical Technology Holdings, Inc.股票交易,Creative Medical Technology Holdings, Inc.股票购买,Creative Medical Technology Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Creative Medical Technology Holdings, Inc.(CELZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Creative Medical Technology Holdings, Inc.(CELZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction